-
March 18: The Week in Cancer News
Metastatic prostate cancer incidence rose after recommendation against routine screening, and FDA approves first PARP inhibitor for early-stage breast cancer for people with inherited BRCA mutations.
by Eric Fitzsimmons
-
March 11: The Week in Cancer News
FDA approves neoadjuvant immunotherapy treatment for lung cancer, and radiation might not be needed for low-risk thyroid cancer.
by Kevin McLaughlin
-
March 4: The Week in Cancer News
Study finds lower rates of screening-related breast cancer overdiagnosis and children with cancer in Ukraine continue treatment in hospital’s basement.
by Marci A. Landsmann
-
February 25: The Week in Cancer News
Screening program reduces disparities in colorectal cancer, and seeing the challenges of getting cancer care through one woman’s story.
by Eric Fitzsimmons
-
November 5: The Week in Cancer News
U.S. map spotlights industrial hot spots for cancer-causing air pollution, and surgery delays after initial treatment impact survival for some patients with locally advanced rectal cancer.
by Marci A. Landsmann
-
June 25: The Week in Cancer News
A reporter discusses the elevated risk for early-onset colorectal cancer in Black men, and a study shows that women are underrepresented in cancer clinical trials.
by Kate Yandell
-
June 11: The Week in Cancer News
Triplet therapy shows promise for prostate cancer that was metastatic at diagnosis, and Americans report inadequate knowledge of palliative care.
by Marci A. Landsmann
-
June 4: The Week in Cancer News
A targeted therapy improves disease-free survival when given to people with certain hereditary mutations after breast cancer surgery, and the Food and Drug Administration approves a new lung cancer treatment targeting a mutated form of the KRAS protein.
by Kevin McLaughlin
-
May 28: The Week in Cancer News
A study finds that many people with solid tumors mount an antibody response following COVID-19 vaccination, and the Food and Drug Administration approves the first targeted therapy for a rare lung cancer subtype.
by Kate Yandell
-
May 14: The Week in Cancer News
Researchers report disappointing results about ovarian cancer screening, and cancer patients with impaired immune function feel uncertain about protection offered by COVID-19 vaccination.
by Marci A. Landsmann
Cancer Talk
Treating HER2-ultralow Breast Cancer
FDA approval expands treatment options for people with metastatic breast cancer that expresses minimal levels of HER2.
by Sandra Gordon
Lessons Learned as a Caregiver and PatientAfter caring for her husband during his cancer treatment, Miriam Díaz-Gilbert was prepared to face her DCIS diagnosis.
by Miriam Díaz-Gilbert
Screening Options for People With Dense BreastsReports on breast density inform women of their status but raise questions about what to do next.
by Robin Roenker
Injection Immunotherapies Get FDA ApprovalGiving immunotherapy drugs as injections, rather than intravenously, means patients can spend less time in the hospital or treatment center.
by Laura Gesualdi-Gilmore